• Login
  • |
  • Register

NGS Leaders Blog

Breaking New Ground at X-GEN Congress

 Permanent link

Glazer_picApril 4, 2011                  

Eric Glazer : Over 150 people filled a ballroom at the San Diego Hilton earlier this month for a panel discussion, hosted by NGS Leaders and our partner GenomeQuest, on WGS applied to clinical diagnostics. The panel discussion was scheduled during Cambridge Healthtech Institute's Second Annual X-GEN Congress & Expo. In addition to the live audience, over 200 members of the NGS Leaders community logged into the webcast. The session was engaging and informative, and we are pleased to provide members of NGS Leaders with access to the on-demand version. xgen_panel1 

In addition to the insights from participants in our panel discussion, I heard many other interesting comments throughout the week at X-GEN Congress, a conference with over 500 attendees from more than 20 countries. Many of the most interesting conversations took place outside of the sessions, in hallways or in smaller roundtables. Here I share some of the more memorable quotes...

· Countries with social medicine are more apt to participate in mass sequencing projects. 
· We need consortia that can educate the public on the risks and rewards of NGS. 
· We need to work together as an industry, even competitors, to educate physicians on leveraging NGS. 
· In 4-5 years, teenagers are going be posting their genome on Facebook for everyone to see. 
· NGS allows us to ask things we didn’t think to ask for.  
· Closing the gap between data and knowledge is our biggest challenge. 
· Making data findings actionable is the most important progress we can make (in next 24-36 months).  
· Harnessing the biologic diversity in the Amazon basin is one of the most important things we can do.  
· NGS can make dramatic changes in how healthcare works.  
· The rain forest holds cures to diseases that have yet to emerge. 



I-Study: Genomic Interpretation - Who Will Pay?
During this webinar, members of the study review team present preliminary findings of the I-Study, conducted at the Harvard Medical School's 2011 Personalized Medicine Conference.
Twitter Feed
Privacy Policy|Terms of Use